title: Intravascular treatment of spinal arteriovenous malformations using a microcatheter--with special reference to serial xylocaine tests and intravascular pressure monitoring.
abstract: Spinal arteriovenous malformations (spinal AVMs) are now treated using microcatheters and various embolic materials. Interventional techniques of this type are thought to be the first choice for treatment of spinal AVMs. In this study, we used the Tracker vascular access system and MAGIC catheter for intravascular treatment of spinal AVMs in order to avoid proximal occlusion. Notably, serial provocation tests using xylocaine (20 mg in bolus) and intermittent intravascular pressure monitoring in the anterior spinal artery were conducted during embolizations of five intramedullary AVMs. We used 150-350 microns polyvinyl alcohol particles (Ivalon) and/or polyvinyl alcohol (PVA) solutions as embolic materials for occlusion of these AVMs. Vital signs and neurologic functions were carefully monitored during and after the procedure. We were able totally to obliterate the nidus or markedly to reduce its size while preserving the anterior spinal artery in each of the patients. The xylocaine test was conducted an average of 2.6 times (2-4 times) during embolization. For the two patients who were treated with Ivalon and PVA solutions, the final provocation test became positive, and the embolization procedure was terminated. On the other hand, the remaining patients had a positive result on first xylocaine test and were treated with Ivalon alone. At the same time, intravascular pressure monitoring was performed via the microcatheter, which was located in the anterior spinal artery. The value of the intravascular systolic pressure prior to embolization was 71.6 +/- 14.1 mm Hg and it gradually increased during the procedure, and reached 99.6 +/- 12.6 mm Hg (90% of the systemic systolic blood pressure) by the conclusion of embolization. Serial xylocaine tests and intravascular pressure monitoring may be useful for the treatment of spinal AVMs fed mainly by the anterior spinal artery, and embolization with liquid embolic material should be terminated when the provocation test becomes positive and intravascular pressure increased to 90% of the systemic blood pressure.
authors.affiliation: Department of Neurosurgery, Osaka Neurological Institute, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Touho
authors.forename: J
authors.initials: J
authors.lastname: Karasawa
authors.forename: H
authors.initials: H
authors.lastname: Ohnishi
authors.forename: K
authors.initials: K
authors.lastname: Yamada
authors.forename: M
authors.initials: M
authors.lastname: Ito
authors.forename: A
authors.initials: A
authors.lastname: Kinoshita
mesh_terms: D000328:Adult; D001165:Arteriovenous Malformations / Q000175:diagnosis* / Q000628:therapy*; D001795:Blood Pressure Determination / Q000379:methods; D002404:Catheterization; D016461:Chemoembolization, Therapeutic / Q000295:instrumentation*; D005260:Female; D006801:Humans; D008012:Lidocaine; D008297:Male; D008991:Monitoring, Physiologic; D011142:Polyvinyl Alcohol / Q000627:therapeutic use; D013116:Spinal Cord / Q000098:blood supply*
chemical_list: D011142:Polyvinyl Alcohol; D008012:Lidocaine